Literature DB >> 16210634

IL-12 is required for induction but not maintenance of protective, memory responses to Blastomyces dermatitidis: implications for vaccine development in immune-deficient hosts.

Marcel Wüthrich1, Tom Warner, Bruce S Klein.   

Abstract

Cellular immunity mediated by T lymphocytes, in particular CD4(+) and CD8(+) type 1 (T1) cells, is the main defense against pathogenic fungi. IL-12 initiates T1 cell development and cell-mediated immunity, but it is unclear whether IL-12 contributes to the maintenance of an antifungal T1 response. In this study, we addressed the role of IL-12 for vaccine-induced memory T cell development against experimental pulmonary blastomycosis. CD4(+) T cells absolutely required IL-12 to control a live genetically engineered attenuated strain of Blastomyces dermatitidis given s.c. as a vaccine, whereas CD8(+) T cells were significantly less dependent on IL-12. Despite differential dependency of T cell subsets on IL-12 during vaccination, neither subset acquired memory immunity in the absence of IL-12. In contrast, adoptive transfer of immune CD4 T cells from wild-type mice into IL-12(-/-) mice showed that CD4(+) T1 memory cells sustained a T1 cytokine profile and remained protective over a period of 6 mo posttransfer. Similarly, memory CD8 cells elicited in IL-12(-/-) mice with killed yeast and transient rIL-12 treatment (during vaccination) remained durable and protective after animals were rested for 3 mo. In conclusion, these studies demonstrate that once CD4 and CD8 cells have acquired a protective T1 phenotype they no longer require the presence of IL-12 to maintain antifungal protective memory.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16210634     DOI: 10.4049/jimmunol.175.8.5288

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  SOCS1 downregulation in dendritic cells promotes memory T-cell responses.

Authors:  Melissa Aldrich; Denise Sanders; Natasha Lapteva; Xue F Huang; Si-Yi Chen
Journal:  Vaccine       Date:  2007-12-07       Impact factor: 3.641

2.  Interleukin 1 enhances vaccine-induced antifungal T-helper 17 cells and resistance against Blastomyces dermatitidis infection.

Authors:  Marcel Wüthrich; Vanessa LeBert; Kevin Galles; Jane Hu-Li; Shlomo Z Ben-Sasson; William E Paul; Bruce S Klein
Journal:  J Infect Dis       Date:  2013-06-20       Impact factor: 5.226

3.  A TCR transgenic mouse reactive with multiple systemic dimorphic fungi.

Authors:  Marcel Wüthrich; Chiung Yu Hung; Ben H Gern; John C Pick-Jacobs; Kevin J Galles; Hanna I Filutowicz; Garry T Cole; Bruce S Klein
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

Review 4.  Cytokines and the regulation of fungus-specific CD4 T cell differentiation.

Authors:  Vanessa Espinosa; Amariliz Rivera
Journal:  Cytokine       Date:  2011-11-30       Impact factor: 3.861

5.  Limited model antigen expression by transgenic fungi induces disparate fates during differentiation of adoptively transferred T cell receptor transgenic CD4+ T cells: robust activation and proliferation with weak effector function during recall.

Authors:  Marcel Wüthrich; Karen Ersland; John C Pick-Jacobs; Benjamin H Gern; Christopher A Frye; Thomas D Sullivan; Meghan B Brennan; Hanna I Filutowicz; Kevin O'Brien; Keegan D Korthauer; Stacey Schultz-Cherry; Bruce S Klein
Journal:  Infect Immun       Date:  2011-11-28       Impact factor: 3.441

6.  V beta1+ J beta1.1+/V alpha2+ J alpha49+ CD4+ T cells mediate resistance against infection with Blastomyces dermatitidis.

Authors:  Marcel Wüthrich; Hanna I Filutowicz; Holly L Allen; George S Deepe; Bruce S Klein
Journal:  Infect Immun       Date:  2006-10-09       Impact factor: 3.441

7.  CD28 is required for optimal induction, but not maintenance, of vaccine-induced immunity to Blastomyces dermatitidis.

Authors:  Marcel Wüthrich; Tom Warner; Bruce S Klein
Journal:  Infect Immun       Date:  2005-11       Impact factor: 3.441

Review 8.  Vaccine immunity against fungal infections.

Authors:  Som G Nanjappa; Bruce S Klein
Journal:  Curr Opin Immunol       Date:  2014-03-03       Impact factor: 7.486

9.  Myeloma cell line-derived, pooled heat shock proteins as a universal vaccine for immunotherapy of multiple myeloma.

Authors:  Jianfei Qian; Sungyoul Hong; Siqing Wang; Liang Zhang; Luhong Sun; Michael Wang; Jing Yang; Larry W Kwak; Jian Hou; Qing Yi
Journal:  Blood       Date:  2009-08-04       Impact factor: 22.113

10.  Vaccine-induced protection against 3 systemic mycoses endemic to North America requires Th17 cells in mice.

Authors:  Marcel Wüthrich; Benjamin Gern; Chiung Yu Hung; Karen Ersland; Nicole Rocco; John Pick-Jacobs; Kevin Galles; Hanna Filutowicz; Thomas Warner; Michael Evans; Garry Cole; Bruce Klein
Journal:  J Clin Invest       Date:  2011-01-04       Impact factor: 19.456

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.